KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 mo.

Tanvi Gupta, Brooks D Cash

Ann Intern Med 177(2) JC15

PMID38315998
PMCID-
DOI10.7326/J23-0122
发表日期2024-02-05
摘要

摘要

Ford AC, Wright-Hughes A, Alderson SL, et al; ATLANTIS trialists. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402:1773-1785. 37858323.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。